dengue fever
Conditions
Interventions
controls:physical reduce fever, ibuprofen, diazepam, Vitamin C and Vitamin B6
trial group:controls's intervetion and Lianbizhi injection
Sponsors
Fuzhou Infectious Disease Hospital
Eligibility
Sex/Gender
All
Age
14 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) patient with dengue-related clinical symptoms and with a history of epidemiology (dengue fever occurred after patient reaching epidemic area within 15 days, or live in areas with dengue cases); or patient with dengue-related clinical symptoms and with leucopenia and thrombopenia; (2) based on Guidelines for diagnosis and treatment of dengue fever (2014 edition), patient with dengue nonstructural 1(NS1) antigen detection or serum IgM antibody are positive; (3) patient aged 14 to 75.
Exclusion criteria
Exclusion criteria: (1) pregnant woman, allergic constitution or allergic to experimental drug composition; (2) patient of renal insufficiency; (3) patient of uncontrolled disease like diabetes, coronary heart disease, liver cirrhosis, or severemalnutrition; (4) patient of severe dengue fever; (5) patient of secondary infection; (6) patient of hemolysis phenomenon; (7) patient participating in other clinical trials within 3 month; (8) patient that the researchers think unsuitable for this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fever relief time;main symptoms relief time; | — |
Secondary
| Measure | Time frame |
|---|---|
| clinical cure rate;time for NS1 antigen turning negative;time for white blood cell (WBC) return to normal;time for platelet (PLT)return to normal; | — |
Countries
China
Contacts
Public ContactQin Li
Fuzhou Infectious Disease Hospital
Outcome results
None listed